SQSTM1 and metastatic malignant neoplasm in the lymph nodes: Instead, only a decreased expression of SQSTM1 (p = 0.006), TFEB (p = 0.011), and PRKAA1 (p = 0.001) could be observed in patients with lymph-node metastases (n = 17).